Australia · Delayed Price · Currency is AUD SciDev Statistics
Total Valuation
SciDev has a market cap or net worth of AUD 82.69 million. The enterprise value is 79.27 million.
| Market Cap | 82.69M |
| Enterprise Value | 79.27M |
Important Dates
The next estimated earnings date is Sunday, February 22, 2026.
| Earnings Date | Feb 22, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SciDev has 190.09 million shares outstanding. The number of shares has increased by 0.07% in one year.
| Current Share Class | 190.09M |
| Shares Outstanding | 190.09M |
| Shares Change (YoY) | +0.07% |
| Shares Change (QoQ) | +0.07% |
| Owned by Insiders (%) | 12.76% |
| Owned by Institutions (%) | 29.94% |
| Float | 123.30M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 18.91 |
| PS Ratio | 0.80 |
| PB Ratio | 1.65 |
| P/TBV Ratio | 3.27 |
| P/FCF Ratio | 105.34 |
| P/OCF Ratio | 28.85 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.12, with an EV/FCF ratio of 100.98.
| EV / Earnings | -90.28 |
| EV / Sales | 0.77 |
| EV / EBITDA | 11.12 |
| EV / EBIT | 26.76 |
| EV / FCF | 100.98 |
Financial Position
The company has a current ratio of 1.56, with a Debt / Equity ratio of 0.13.
| Current Ratio | 1.56 |
| Quick Ratio | 1.17 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | 0.88 |
| Debt / FCF | 7.98 |
| Interest Coverage | 4.72 |
Financial Efficiency
Return on equity (ROE) is -1.75% and return on invested capital (ROIC) is -3.83%.
| Return on Equity (ROE) | -1.75% |
| Return on Assets (ROA) | 2.51% |
| Return on Invested Capital (ROIC) | -3.83% |
| Return on Capital Employed (ROCE) | 5.54% |
| Weighted Average Cost of Capital (WACC) | 9.75% |
| Revenue Per Employee | 4.70M |
| Profits Per Employee | -39,909 |
| Employee Count | 22 |
| Asset Turnover | 1.41 |
| Inventory Turnover | 9.38 |
Taxes
In the past 12 months, SciDev has paid 2.33 million in taxes.
| Income Tax | 2.33M |
| Effective Tax Rate | 160.30% |
Stock Price Statistics
The stock price has decreased by -12.12% in the last 52 weeks. The beta is 1.22, so SciDev's price volatility has been higher than the market average.
| Beta (5Y) | 1.22 |
| 52-Week Price Change | -12.12% |
| 50-Day Moving Average | 0.45 |
| 200-Day Moving Average | 0.36 |
| Relative Strength Index (RSI) | 46.56 |
| Average Volume (20 Days) | 187,193 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SciDev had revenue of AUD 103.50 million and -878,000 in losses. Loss per share was -0.01.
| Revenue | 103.50M |
| Gross Profit | 33.39M |
| Operating Income | 2.96M |
| Pretax Income | 1.46M |
| Net Income | -878,000 |
| EBITDA | 5.91M |
| EBIT | 2.96M |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 9.68 million in cash and 6.26 million in debt, with a net cash position of 3.42 million or 0.02 per share.
| Cash & Cash Equivalents | 9.68M |
| Total Debt | 6.26M |
| Net Cash | 3.42M |
| Net Cash Per Share | 0.02 |
| Equity (Book Value) | 50.05M |
| Book Value Per Share | 0.26 |
| Working Capital | 12.07M |
Cash Flow
In the last 12 months, operating cash flow was 2.87 million and capital expenditures -2.08 million, giving a free cash flow of 785,000.
| Operating Cash Flow | 2.87M |
| Capital Expenditures | -2.08M |
| Free Cash Flow | 785,000 |
| FCF Per Share | 0.00 |
Margins
Gross margin is 32.26%, with operating and profit margins of 2.86% and -0.85%.
| Gross Margin | 32.26% |
| Operating Margin | 2.86% |
| Pretax Margin | 1.41% |
| Profit Margin | -0.85% |
| EBITDA Margin | 5.71% |
| EBIT Margin | 2.86% |
| FCF Margin | 0.76% |
Dividends & Yields
SciDev does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.07% |
| Shareholder Yield | -0.07% |
| Earnings Yield | -1.06% |
| FCF Yield | 0.95% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on December 3, 2018. It was a reverse split with a ratio of 0.1.
| Last Split Date | Dec 3, 2018 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
SciDev has an Altman Z-Score of 2.56 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.56 |
| Piotroski F-Score | 5 |